Clinical Trials
5 trialsNCT06125795 2026-05-01
PROVIDENCE
AbbVie
Active not recruiting
NCT05377957 2026-04-15
PROQEM
Leiden University Medical Center
Active not recruiting
NCT06101134 2026-04-09
A Study to Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations
Bristol-Myers Squibb
Phase 2 Active not recruiting
NCT06046625 2025-04-04
Needs and Preferences of Patients With Head-neck Cutaneous SCC
Maastricht University Medical Center
Active not recruiting
NCT05883956 2025-03-20
PREFER-HMA
Otsuka Australia Pharmaceutical Pty Ltd
Phase 3 Active not recruiting